Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-2

Eli Lilly · Phase 3 · Completed · Enrollment 938

NCT04657003

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
10 milligrams (mg) Tirzepatiden/rn/rn/rn/rn/r
15 mg Tirzepatide68 participants40 participants66 participantsn/r0
Placebo20 participants10 participants28 participantsn/r0
10 mg Tirzepatide63 participants34 participants62 participantsn/r2

A count stays a count. This page does not turn a count into a percent.